ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,696 | -70.0% | 4,120 | -28.0% | 0.00% | – |
| Q2 2023 | $12,300 | – | 5,721 | +8981.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 63 | -97.9% | 0.00% | – |
| Q4 2022 | $11 | -100.0% | 2,935 | -69.0% | 0.00% | -100.0% |
| Q3 2022 | $46,000 | +666.7% | 9,473 | +1253.3% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 700 | -5.0% | 0.00% | – |
| Q1 2022 | $10,000 | -77.3% | 737 | -66.3% | 0.00% | -100.0% |
| Q4 2021 | $44,000 | +4300.0% | 2,189 | +4764.4% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 45 | -45.1% | 0.00% | – |
| Q1 2021 | $2,000 | -98.6% | 82 | -98.2% | 0.00% | -100.0% |
| Q4 2020 | $147,000 | – | 4,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $4,555,066 | 2.69% |
| Blue Owl Capital Holdings LP | 733,568 | $2,816,901 | 1.20% |
| Redmile Group, LLC | 7,590,849 | $29,148,860 | 1.19% |
| AlphaCentric Advisors LLC | 297,500 | $1,142,400 | 1.13% |
| Prosight Management, LP | 463,310 | $1,779,110 | 0.97% |
| GCM Grosvenor Holdings, LLC | 735,471 | $2,824,209 | 0.72% |
| Indie Asset Partners, LLC | 93,839 | $360,342 | 0.40% |
| XTX Topco Ltd | 197,635 | $758,918 | 0.16% |
| Eventide Asset Management | 1,879,959 | $7,219,043 | 0.14% |
| Nantahala Capital Management | 243,290 | $934,234 | 0.06% |